FN1 and ovarian cancer: Chao and his colleagues reported that LMX1A could inhibit the EMT pathway by upregulating the epithelial marker CDH1 and downregulating the mesenchymal markers CDH2 and FN1 by repressing the EMT-related transcription factors SNAIL, SLUG, and SIP1 in ovarian cancer [25].